Manas AI, a NYC-based AI native drug discovery and development company, raised $26M in Seed extension funding. Backers included The General Partnership, Wisdom Ventures, Blitzscaling Ventures, Westbound Equity Partners, Mosaic Ventures, and others. Now PlayingUp NextAlpha: AI-Powered Investment Research | Public1:32Now PlayingUp NextThe Ultimate Free AI Tool for Research Google AI Mode8:28Now PlayingUp NextApple Pushes Deeper Into AI With New Chips, Moving Toward Independence And Stronger AI Int...